AlenCiken

AlenCiken

UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19 www.globenewswire.com

AlenCiken

New data independently confirms and extends laboratory findings and expands safety profile of ATH434 new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of Parkinson's Disease and Movement Disorders (MDS 2020) and the American Neurological...

AlenCiken

SilverSun Technologies Acquires Prairie Technology Solutions Group This acquisition will help us in our plans to expand our MSP business to other regions where we currently have significant numbers of customers from our other technology businesses, including Phoenix, Southern California, the Pacific Northwest, and North Carolina.”...

AlenCiken

O2TODAY Announces Agreement to Develop Antimicrobial Face Masks with SINTX Technologies, Inc. to Help Prevent Spread of COVID-19 and Other Viral Diseases. O2TODAY and SINTX Technologies intend to capitalize on recent and promising data demonstrating the potential of SINTX’s silicon nitride powder to inactivate the SARS-CoV-2 virus that is responsible for the...

AlenCiken

Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva -- Test gives simple positive or negative color change results in 30 minutes or less -- No special laboratory equipment required, hence practical for on-site deployment -- Test uses saliva, eliminating need for painful nasal swabbing -- Study...

AlenCiken

Precipio Launches Covid-19 Antibody Test in its CLIA laboratory Completed the internal validation of the FDA-approved COVID-19 serology antibody test in its CLIA laboratory. Launched the test commercially to its pathology customer base (phase 1) Upon obtaining further approval for expanded use by FDA, phase 2 will broaden our distribution to POC (point-of-care)...

AlenCiken

WKHS has a 10% stake in Lordstown Motors, which, will merge with DiamondPeak (DPHC)-SPAC company Sympathy play www.investors.com

AlenCiken

Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis Study Meets Primary and Key Secondary Endpoints with High Statistical Significance Statistically Significant Reduction of 62% and 70% Data Supports Previously Observed Favorable Safety Profile of IMU-838 in...

AlenCiken

After the Food and Drug Administration approved collaboration partner Clinical Reference Laboratory's saliva test for COVID-19, CODX shares soared 28.3% on Monday. One of the biggest private lab companies in the United States, Clinical Reference Laboratory (CRL) developed its saliva COVID-19 test using Co-Diagnostics CoPrimer technology to boost sensitivity and...

AlenCiken

Jumia to Announce Second Quarter 2020 Results on August 12, 2020 Investors now seem to be turning to the African growth stock, as it does offer considerable upside potential. Often called "the Amazon of Africa," pandemic could be just what Jumia needs to unlock its growth potential and set the company on a path to profitability. Investors on Twitter were...

AlenCiken

Highway Holdings Announces Delay in Reporting Fiscal 2020 Results Due to...

AlenCiken

CymaBay Announces Positive Topline Results from ENHANCE for Seladelpar in Patients with Primary Biliary Cholangitis -The study demonstrated seladelpar to be efficacious, safe and well-tolerated 78.2% of patients on seladelpar 10 mg versus 12.5% on placebo achieved the primary composite outcome after only 3 months (p<0.0001) - 27.3% of patients on seladelpar...

AlenCiken

Cohen & Company Announces Successful Launch of €375 Million PriDe III Funds focus on investing in Tier II capital instruments issued by small and mid-size insurance companies that have limited access to capital markets. The PriDe Program enables insurers to enhance their regulatory capital ratios, fund acquisitions or internal growth, reduce reinsurance costs...

AlenCiken

Pitney Bowes Secures $5 Million Shipping and Mailing Technology Contracts with Government Agency Government agencies – like businesses of all sizes across many industries - are currently facing immense pressures, rethinking processes across multiple parts of their organizations and transforming operations to accommodate a new way of working, often while facing...

AlenCiken

Datasea Signs its First Agreement in Beijing, China to Install its Proprietary Monitoring System The total value of this engagement over the three-year term of this engagement is RMB or approximately $ ; this engagement will be the first-of-its-kind arrangement for the Company in...

AlenCiken

ADT and Google Partner To Create Leading Smart Home Security Offering -Google to invest $450 million to acquire 6.6% ownership in ADT, cementing mutual, long-term commitment to partnership -Each company to commit $150 million for co-marketing, product development, technology and employee training -Partnership will provide customers with integrated smart home...

AlenCiken

electroCore Provides Update on Availability of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients Initial distribution to hospitals and patients expected to begin on July 31st The gammaCore Sapphire CV list price is $1,750. electroCore will be offering gammaCore Sapphire CV to all customers for $1,250...

AlenCiken

O2Micro Hits Profitability and Positive EBITDA in Q2 Operational and Strategic Highlights: Q2 2020 revenue was 17.3 Million, up 21.1% from the same quarter in the previous year and up 10.9% sequentially and within the range of guidance provided on May 8th, 2020. GAAP net income per fully diluted ADS in the second quarter of 2020 was 1 cent, with non-GAAP net...